Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,197,341

« Back to Dashboard

Which drugs does patent 6,197,341 protect, and when does it expire?

Patent 6,197,341 protects GIAZO and is included in one NDA. There has been one Paragraph IV challenge on Giazo.

This patent has fourteen patent family members in fourteen countries.

Summary for Patent: 6,197,341

Title: Formulations of balsalazide and its derivatives
Abstract:The invention provides a unit formulation which comprises a 2-hydroxy-5-phenylazobenzoic acid derivative which is particularly sodium balsalazide dihydrate which formulation has a density of at least 0.9 mg/mm.sup.3 and its use in the treatment of gastrointestinal diseases.
Inventor(s): Friess; Stefan (S-22587 Hamburg, DE), Heckenmuller; Harald (D-22559 Hamburg, DE), Szambien; Oliver (D-23611 Bad Schwartau, DE)
Application Number:09/068,823
Patent Claim Types:
see list of patent claims
Formulation; Compound; Composition; Dosage form; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Valeant Pharms IntlGIAZObalsalazide disodiumTABLET;ORAL022205-001Feb 3, 2012ABRXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF MILDLY TO MODERATELY ACTIVE ULCERATIVE COLITIS IN MALE PATIENTS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,197,341

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9700934-4Mar 14, 1997

International Patent Family for Patent: 6,197,341

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia6430198► Subscribe
Belgium1011837► Subscribe
Brazil9808140► Subscribe
Canada2283297► Subscribe
European Patent Office1003524► Subscribe
France2760638► Subscribe
Greece980100096► Subscribe
Hungary0000850► Subscribe
Japan2001519782► Subscribe
Netherlands1008575► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
US Army
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: